JT Pharmaceutcials Inc develops peptide-based therapeutics, focusing on pain management drugs. The company's goal is to use its proprietary peptide modifcation technology to convert bioactive peptides into new drugs. This modification technology stabilizes peptides, which are naturally unstable in biological environments; promotes peptide penetration of biological barriers; and enhances peptide selectivity for specific receptors. JT Pharamceuticals' propriety technology for peptide therapeutics may have applications in in the treatment of schizophrenia and complications caused by stroke, as well as pain management . The company aims to take advantage of the benefits of peptide-based drugs, including shorter and more predictable development cycles, patent exclusivity related to peptide molecules, and potential for innovation.
